Yatin Suneja

Stock Analyst at Guggenheim

(1.19)
# 1724
Out of 5,329 analysts
142
Total ratings
43.53%
Success rate
-3.84%
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
REGN Regeneron Pharmaceut...
Maintains: Buy
940 810
588.6 37.61% 6 May 1, 2025
PHAT Phathom Pharmaceutic...
Reiterates: Buy
n/a
n/a n/a 3 Apr 2, 2025
CABA Cabaletta Bio
Reiterates: Buy
23 23
1.26 1725.4% 3 Apr 1, 2025
ZURA Zura Bio
Reiterates: Buy
15 15
1.47 920.41% 2 Mar 26, 2025
IFRX InflaRx
Maintains: Strong Buy
7 10
1.85 440.54% 5 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
26 26
2.85 812.28% 4 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
0.63 1011.11% 1 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 8 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
84 84
21.88 283.91% 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
11.56 289.27% 3 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
775 1100
638.88 72.18% 9 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
165 163
106.71 52.75% 4 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
45 45
10.26 338.6% 3 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 20
14.59 37.08% 6 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 36
21.72 65.75% 11 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
14.68 342.78% 1 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
155 170
38.16 345.49% 2 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
32
3.81 739.9% 1 Jul 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
6.92 622.54% 1 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
72 90
20.75 333.73% 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
110 125
112.47 11.14% 8 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
16 32
n/a n/a 3 Jan 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 16
11.59 38.05% 2 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
70 77
41.52 85.45% 3 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jul 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
49
38.18 28.34% 2 Jun 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
52 55
7.12 672.47% 2 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
270 350
121 189.26% 3 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
225 200
n/a n/a 3 Apr 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Jan 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
98 117
n/a n/a 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
n/a n/a 1 Oct 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
11.55 107.79% 1 May 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 34
72.25 -52.94% 2 Jan 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Feb 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
60 80
n/a n/a 2 Jun 11, 2018